Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 45

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 45
---
 is determined in accordance
with the rules of the SEC, and generally includes any ordinary shares over which a person exercises sole or shared voting or investment
power, or the right to receive the economic benefit of ownership. For purposes of the table below, we deem shares subject to warrants
and options that are currently exercisable or exercisable within 60 days of March 17, 2025, and RSUs that are currently vested or
will become vested within 60 days of March 17, 2025, to be outstanding and to be beneficially owned by the person holding the warrants
or options for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose
of computing the percentage ownership of any other person.

The percentage of shares beneficially owned by any shareholder
has been calculated based on 6,672,173 ordinary shares outstanding as of March 17, 2025. Unless otherwise indicated below, to our
knowledge, all persons named in the table have sole voting and investment power with respect to their shares, except to the extent that
authority is shared by spouses under community property laws.

Unless otherwise noted below, each shareholder’s address
is c/o Evogene Ltd., 13 Gad Feinstein Street, Park Rehovot, Rehovot 7638517, Israel. The shareholders listed below (including our directors
and executive officers) do not have any different voting rights than any of our other shareholders. We know of no arrangements that would,
at a subsequent date, result in a change of control of our company. A description of any material relationship that our principal shareholders
have had with us or any of our predecessors or affiliates within the past year is included under “ Item 7. Major Shareholders and
Related Party Transactions - B. Related Party Transactions.”

95

                                                                      Shares Beneficially Held                     
  Name of Beneficial Owner                                                              Number                     
  Executive Officers and Directors                                                                                 
  Mr. Ofer Haviv                                                                        89,500       (1)      1.3  
  Mr. Yaron Eldad                                                                       17,050       (2)      *    
  Dr. Dan Jacob Gelvan                                                                       0                *    
  Dr. Elran Haber                                                                        2,500       (3)      *    
  Mr. Amit Noam                                                                              0                *    
  Dr. Gabi Tarcic                                                                            0                *    
  Mr. Ilia Zhidkov                                                                      16,250